Generare

Description

Generare turns unexplored microbial chemistry into screenable molecules for drug discovery by selecting microbes with rare biosynthetic instructions, capturing those instructions in parallel, testing enriched extracts, and producing hits in engineered hosts for resupply.

Generare is located in the Paris ecosystem.

Related

• BiosyntiaBiosyntia produces natural ingredients using proprietary microbial fermentation processes, selecting and integrating engineered microbes…
• IktosIktos builds generative AI and robotics systems for drug discovery, producing platforms for de novo molecule design, retrosynthesis…
• EntalpicEntalpic builds AI-driven materials and molecule discovery platforms that combine machine learning, quantum/atomistic simulation and…
• C12 Quantum ElectronicsC12 Quantum Electronics builds carbon-based quantum computers, using carbon-centered materials and architecture to improve qubit quality…
• AviwellAviwell develops microbiota-based feed solutions and AI-driven discovery tools for livestock producers, producing direct-fed microbials and…
• PurposefulPurposeful repurposes marketed drugs to find treatments and develop pharmaceutical products for rare diseases, with an AI repurposing…
• Qubit PharmaceuticalsQubit Pharmaceuticals develops quantum- and AI-driven molecular modeling platforms and drug discovery tools used to design novel drug…
• Common Sense RoboticsCommon Sense Robotics offers an AI-powered Task Execution Software platform that translates work instructions into reliable robotic…
• Spore BiotechnologiesSpore Biotechnologies builds an AI-based, direct microbiology testing system that uses transformer-based multimodal spectral imaging to…